Sensulin is a preclinical biopharmaceutical company, that is developing a glucose-responsive insulin for type 1 and type 2 diabetes. Sensulin aims to substantially lower the risk of hypoglycemia, reduce the long-term complications associated with diabetes (eye & kidney disease, etc.), while
Location: United States, Oklahoma, Oklahoma City
Employees: 11-50
Founded date: 2011
Investors 5
| Date | Name | Website |
| - | Cowboy Tec... | cowboytech... |
| - | Cortado Ve... | cortado.ve... |
| - | MassChalle... | masschalle... |
| - | Biobrit | biobrit.co... |
| - | FundRx | fundrx.com |
Mentions in press and media 2
| Date | Title | Description | Source |
| 25.05.2018 | Sensulin Raises Undisclosed Series B Funding Round | Sensulin, an Oklahoma City, Ok-based biotechnology company, raised an undisclosed Series B funding r... | finsmes.co... |
| 13.01.2016 | Propel(X) Raised $3.6 Million for Tech Startups in 2015 | Propel(x), an angel crowdfunding platform that helps individuals source promising technology startup... | crowdfundi... |